The Nexus ANS+ assesses the patient's risk of autonomic nervous system and arterial dysfunction related to disorders and disease associated with chronic metabolic diseases. The assessment is non-invasive and is performed in less than 8 minutes. A typical practice can test 15 or more patients daily with one machine.
More than 45,000,000 Americans present with symptoms or risk factors that may make them candidates for this testing.
Patients that present with any of the following symptoms may be candidates for testing:
- Pain, numbness, tingling, or burning in the feet
- Leg pain after effort, claudication
- Dizziness, syncope
Patients over the age of 50 that have been diagnosed with any of the following may be candidates for testing:
- Any patient over the age of 70 may be a candidate for testing
Over 60% of Americans over the age of 55 suffer from hypertension. Approximately 20% of Americans aged 45 to 64 are smokers. 40% of patients over the age of 50 are obese. 12 Million suffer from lower extremity disease. 15-20% of people over 60 years old have artery and ANS damage. The CDC projects that 1 in 3 adults could have diabetes by 2050.
The Nexus ANS+ aids in the early detection of autonomic nervous system and arterial conditions while simplifying information for physicians.
The arterial risk assessment includes:
- Skin microcirculatory disorder
- Arterial stiffness
- Peripheral artery disease
- Small fiber neuropathy
- Autonomic dysregulation
- Cardiac autonomic neuropathy
Please review the results screen PDF on the right side of this page. There is also a five-page physician's report generated by the system that is broken down as follows:
- Arterial stiffness assessment
- Peripheral artery disease assessment
- Sudomotor function assessment
- Autonomic regulation assessment
- Cardiac autonomic neuropathy assessment
Contact us for more information, to discuss the average ROI, or to discuss how the Nexus ANS+ may assist you in the early detection of autonomic nervous system and arterial conditions in your patients.
Nexus ANS+ - Early Detection - Proactive Treatment - Attractive Reimbursement